Resection of recurrent pulmonary metastases in patients with osteosarcoma
β Scribed by Antonio Briccoli; Michele Rocca; Mariacristina Salone; Gaetano Bacci; Stefano Ferrari; Alba Balladelli; Mario Mercuri
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 81 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
BACKGROUND
Surgical resection of lung metastases is widely accepted in osteosarcoma patients. Few data exist on treatment of recurrent pulmonary metastases. The authors of the current study retrospectively analyzed patients with osteosarcoma who received surgery for recurrent lung metastases.
METHODS
From 1980 to 2001, 127 metastasectomies were performed on 94 patients. Criteria of eligibility were no metastases beyond the lung, no local recurrence, possibility of achieving complete resection of metastases without causing respiratory insufficiency, acceptable operative risk. Data were statistically elaborated with survival analysis according to KaplanβMeier method of univariate analysis, life tables and Gehan statistic model, and multivariate analysis using Cox regression test. Results were considered in terms of time from first (DFI^1^) and second (DFI^2^) metastasectomy.
RESULTS
Of 94 patients operated upon twice, 59 (62.7%) died. Thirtyβfive (37.3%) are alive; 31 (32.9%) of these are continuously diseaseβfree. The 3β and 5βyear eventβfree actuarial survival curve from first metastasectomy was 45%, and 38%, respectively, whereas from the second metastasectomy, it was 33% and 32%, respectively. According to a Cox regression model, DFI^1^ has a risk of death of 0.974 times and DFI^2^ of 0.972 times for every additional month of survival. In multivariate analysis, Cox regression test showed the best predictive model of local recurrence and number of metastases (P = 0.0014).
CONCLUSIONS
The authors concluded that patients persistently free of the primary osteosarcoma who developed recurrent resectable metastatic disease of the lung should be considered for reoperation a second, third, or fourth time, as these patients had similar DFI curves after fiveβyears. Cancer 2005. Β© 2005 American Cancer Society.
π SIMILAR VOLUMES
Hideyuki Omoto, M.D. ## RESULTS. Five of the patients included four who underwent pulmonary resection Nobuyuki Nakajima, M.D. for pulmonary metastases after initial hepatic resection for hepatic metastases and one patient who underwent hepatic metastasis resection after initial pulmonary The Fir
## Resection of Hepatic and Pulmonary Metastases in Patients with Colorectal Carcinoma W e read with interest the article by Ambiru et al. 1 concerning the resection of colorectal hepatic and pulmonary metastases. In a population of 156 patients with resected hepatic metastases from colorectal car
## BACKGROUND. More than 40% of patients who undergo curative resection of advanced colorectal carcinoma can be expected to have recurrence of the disease. The most frequent sites of recurrence are the liver (33% of patients) and lung (22%). Interest has therefore focused on treating hepatic or
Background. Literature shows no data about a complete cohort of head and neck cancer patients who developed pulmonary metastases. In this study, we investigate factors related to survival, with emphasis on the role of a pulmonary metastasectomy. Methods. A retrospective review of 138 patients who d